These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum. Rucińska M; Furman M; Skrzydlewski Z; Zaremba E Acta Biochim Pol; 1997; 44(1):109-12. PubMed ID: 9241361 [TBL] [Abstract][Full Text] [Related]
24. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306 [TBL] [Abstract][Full Text] [Related]
25. [Interrelationship between blood coagulation system indices and biogenic amines in stomach cancer]. Agaev IN Vopr Onkol; 1981; 27(1):111-2. PubMed ID: 7456439 [No Abstract] [Full Text] [Related]
26. Increase of regulatory T cells in the peripheral blood of cancer patients. Wolf AM; Wolf D; Steurer M; Gastl G; Gunsilius E; Grubeck-Loebenstein B Clin Cancer Res; 2003 Feb; 9(2):606-12. PubMed ID: 12576425 [TBL] [Abstract][Full Text] [Related]
27. [Comparative research on blood amino acids among carriers of neoplasms in the digestive tract and other locations]. Morisio Guidetti L Boll Soc Ital Biol Sper; 1983 Oct; 59(10):1531-7. PubMed ID: 6661316 [TBL] [Abstract][Full Text] [Related]
28. [Changes in hemostasis in patients with cancer of the stomach]. Marusov AA; Skipetrov VP; Shelestiuk PI Vopr Onkol; 1987; 33(11):70-3. PubMed ID: 3686926 [TBL] [Abstract][Full Text] [Related]
29. [State of blood coagulation and capillary permeability in patients with lung cancer]. Kravchenko LF; Topchienko VS Ter Arkh; 1976; 40(2):84-7. PubMed ID: 968767 [No Abstract] [Full Text] [Related]
30. [State of the blood coagulation and anticoagulation system in radiation therapy of lung cancer]. Strashinin AI; Evdokimov NM; Zlydnikov DM Vopr Onkol; 1971; 17(1):78-9. PubMed ID: 5574584 [No Abstract] [Full Text] [Related]
31. [Blood group studies in malignant neoplastic diseases]. Hartmann E; Rex-Kiss B Ann Immunol Hung; 1973; 17():193-203. PubMed ID: 4218934 [No Abstract] [Full Text] [Related]
32. [Evaluation of the functional state of the complement and fibrinolysis systems]. Tiutrin II; Smol'ianinov ES; Udut VV; Vasil'ev NV; Tsisik RM Lab Delo; 1989; (12):43-5. PubMed ID: 2483203 [TBL] [Abstract][Full Text] [Related]
33. [Blood coagulation system in patients with malignant and inflammatory processes of the lungs]. Khrushcheva EA; Titova MI; Adamian AA Klin Med (Mosk); 1971 Nov; 49(11):52-6. PubMed ID: 5141900 [No Abstract] [Full Text] [Related]
34. Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Kinjo M; Oka K; Naito S; Kohga S; Tanaka K; Oboshi S; Hayata Y; Yasumoto K Br J Cancer; 1979 Jan; 39(1):15-23. PubMed ID: 758928 [TBL] [Abstract][Full Text] [Related]
35. [Effects of combined hormone therapy on the coagulation-fibrinolytic systems in patients with advanced breast cancer]. Fukutomi T; Adachi I; Watanabe T; Nanasawa T; Yamamoto H Gan To Kagaku Ryoho; 1993 May; 20(7):957-9. PubMed ID: 8489302 [No Abstract] [Full Text] [Related]
36. ABO blood group distribution in relation to malignancies in Egypt. Hammouda F; Soliman HA; Hussein MH J Egypt Med Assoc; 1972; 55(8):655-60. PubMed ID: 4664110 [No Abstract] [Full Text] [Related]
38. [Transketolase activity and thiamine diphosphate content in oncological patients]. Trebukhina RV; Tumanov VN; Avdeĭchik LA; Bobko IN; Tsabenko II Vopr Med Khim; 1983; 29(5):100-3. PubMed ID: 6649520 [TBL] [Abstract][Full Text] [Related]
39. [The effect of cancer patients serum on the biological properties of Staphylococcus aureus]. Kochetkova VA Vopr Onkol; 1969; 15(3):34-8. PubMed ID: 5406690 [No Abstract] [Full Text] [Related]